Artivion | CRY - Ebitda

Stock Price
22.77
Daily Change
-0.16 -0.70%
Monthly
-38.02%
Yearly
-22.84%
Q2 Forecast
24.88

Artivion reported $22.72M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 17.07M 2.79M Mar/2026
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Boston Scientific USD 1.16B 213M Dec/2025
Edwards Lifesciences USD 70.1M 394.2M Dec/2025
Integra LifeSciences USD 76.18M 28.03M Mar/2026
J&J USD 7.19B 2.32B Dec/2025
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Pfizer USD 5.99B 5.23B Mar/2026
ResMed USD 547.48M 27.46M Dec/2025
Stryker USD 1.57B 618M Mar/2026
Surmodics USD 3.43M 1.9M Jun/2025
Tandem Diabetes Care USD 2.73M 30.17M Mar/2026
Teleflex USD 247.07M 575.88M Dec/2025
Terumo JPY 57.88B 12.1B Mar/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024